Literature DB >> 8108441

A subset of HLA-B27 molecules contains peptides much longer than nonamers.

R G Urban1, R M Chicz, W S Lane, J L Strominger, A Rehm, M J Kenter, F G UytdeHaag, H Ploegh, B Uchanska-Ziegler, A Ziegler.   

Abstract

An unusual monoclonal antibody (MARB4) directed against HLA-B27 that reacts with only approximately 5-20% of the cell surface HLA-B27 was used for large-scale purification of these molecules. Subsequent mass spectrometry of HLA-B27-bound peptides showed that the minor MARB4-reactive population contained peptides primarily from 900 to 4000 Da in size (approximately 8-33 amino acid residues), whereas the major HLA-B27 population contained peptides in the mass range of 900-1400 Da (approximately 8-12 amino acid residues). Thus, a subset of HLA-B27 molecules binds to peptides much longer than nonamers. Typical HLA-B27-binding peptides contain arginine in position 2. Further analysis by Edman sequencing of the pooled bound peptides revealed that the major population contained substantial amounts of arginine at positions 1 and 9 (40-50%) and exclusively arginine at position 2, as expected. The minor population of peptides also contained detectable amounts of arginine at these positions, but at the level of only approximately 10%; no marked enrichment at any position was observed. These long HLA-B27-bound peptides could represent either intermediates in the formation of nonamers or adventitiously bound peptides. Lastly, in the TAP2 mutant cell line BM36.1 transfected with HLA-B*2705, MARB4-reactive HLA-B27 molecules were absent from the cell surface, indicating that the peptide transporter was required for delivery of the long peptides. Thus, during the folding of class I heavy chains, peptides of diverse lengths are available and participating.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8108441      PMCID: PMC43194          DOI: 10.1073/pnas.91.4.1534

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Cellular peptide composition governed by major histocompatibility complex class I molecules.

Authors:  K Falk; O Rötzschke; H G Rammensee
Journal:  Nature       Date:  1990-11-15       Impact factor: 49.962

Review 2.  Guilt by association: HLA-B27 and ankylosing spondylitis.

Authors:  R Benjamin; P Parham
Journal:  Immunol Today       Date:  1990-04

3.  Specificity pockets for the side chains of peptide antigens in HLA-Aw68.

Authors:  T P Garrett; M A Saper; P J Bjorkman; J L Strominger; D C Wiley
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

4.  A small polypeptide different from beta2-microglobin associated with a human cell surface antigen.

Authors:  A Ziegler; C Milstein
Journal:  Nature       Date:  1979-05-17       Impact factor: 49.962

5.  Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner.

Authors:  M J Androlewicz; K S Anderson; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

6.  Monoclonal antibody (Tü48) defining alloantigenic class I determinants specific for HLA-Bw4 and HLA-Aw23,-Aw24 as well as -Aw32.

Authors:  C Müller; A Ziegler; G Müller; F Schunter; P Wernet
Journal:  Hum Immunol       Date:  1982-12       Impact factor: 2.850

7.  Organization, sequence and expression of the HLA-B27 gene: a molecular approach to analyze HLA and disease associations.

Authors:  E H Weiss; W Kuon; C Dörner; M Lang; G Riethmüller
Journal:  Immunobiology       Date:  1985-12       Impact factor: 3.144

8.  The construction of cosmid libraries which can be used to transform eukaryotic cells.

Authors:  F G Grosveld; T Lund; E J Murray; A L Mellor; H H Dahl; R A Flavell
Journal:  Nucleic Acids Res       Date:  1982-11-11       Impact factor: 16.971

9.  Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2.

Authors:  F Gotch; J Rothbard; K Howland; A Townsend; A McMichael
Journal:  Nature       Date:  1987 Apr 30-May 6       Impact factor: 49.962

10.  Comparison between two peptide epitopes presented to cytotoxic T lymphocytes by HLA-A2. Evidence for discrete locations within HLA-A2.

Authors:  P A Robbins; L A Lettice; P Rota; J Santos-Aguado; J Rothbard; A J McMichael; J L Strominger
Journal:  J Immunol       Date:  1989-12-15       Impact factor: 5.422

View more
  36 in total

1.  Antigen processing for MHC class I restricted presentation of exogenous influenza A virus nucleoprotein by B-lymphoblastoid cells.

Authors:  J T Voeten; G F Rimmelzwaan; N J Nieuwkoop; R A Fouchier; A D Osterhaus
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

2.  Influence of dominant HIV-1 epitopes on HLA-A3/peptide complex formation.

Authors:  Judith Racape; Francine Connan; Johan Hoebeke; Jeannine Choppin; Jean-Gérard Guillet
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-20       Impact factor: 11.205

3.  Shigella induced reactive arthritis.

Authors:  J S Hill Gaston
Journal:  Ann Rheum Dis       Date:  2005-04       Impact factor: 19.103

4.  Sampling of major histocompatibility complex class I-associated peptidome suggests relatively looser global association of HLA-B*5101 with peptides.

Authors:  Daniel Gebreselassie; Hans Spiegel; Stanislav Vukmanovic
Journal:  Hum Immunol       Date:  2006-09-20       Impact factor: 2.850

5.  Expression, purification and preliminary X-ray crystallographic analysis of the human major histocompatibility antigen HLA-B*1402 in complex with a viral peptide and with a self-peptide.

Authors:  Pravin Kumar; Ardeschir Vahedi-Faridi; Elena Merino; José A López de Castro; Armin Volz; Andreas Ziegler; Wolfram Saenger; Barbara Uchanska-Ziegler
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-06-29

6.  Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance.

Authors:  Stefan Tenzer; Edmund Wee; Anne Burgevin; Guillaume Stewart-Jones; Lone Friis; Kasper Lamberth; Chih-hao Chang; Mikkel Harndahl; Mirjana Weimershaus; Jan Gerstoft; Nadja Akkad; Paul Klenerman; Lars Fugger; E Yvonne Jones; Andrew J McMichael; Søren Buus; Hansjörg Schild; Peter van Endert; Astrid K N Iversen
Journal:  Nat Immunol       Date:  2009-05-03       Impact factor: 25.606

7.  The Human Leukocyte Antigen (HLA)-B27 Peptidome in Vivo, in Spondyloarthritis-susceptible HLA-B27 Transgenic Rats and the Effect of Erap1 Deletion.

Authors:  Eilon Barnea; Dganit Melamed Kadosh; Yael Haimovich; Nimman Satumtira; Martha L Dorris; Mylinh T Nguyen; Robert E Hammer; Tri M Tran; Robert A Colbert; Joel D Taurog; Arie Admon
Journal:  Mol Cell Proteomics       Date:  2017-02-10       Impact factor: 5.911

8.  Characterization of a proteasome and TAP-independent presentation of intracellular epitopes by HLA-B27 molecules.

Authors:  Adriana Magnacca; Irene Persiconi; Elisa Nurzia; Silvana Caristi; Francesca Meloni; Vincenzo Barnaba; Fabiana Paladini; Domenico Raimondo; Maria Teresa Fiorillo; Rosa Sorrentino
Journal:  J Biol Chem       Date:  2012-07-17       Impact factor: 5.157

9.  ERAP1 reduces accumulation of aberrant and disulfide-linked forms of HLA-B27 on the cell surface.

Authors:  Tri M Tran; Sohee Hong; Jehad H Edwan; Robert A Colbert
Journal:  Mol Immunol       Date:  2016-04-22       Impact factor: 4.407

10.  Alteration of HLA-B27 peptide presentation after infection of transfected murine L cells by Shigella flexneri.

Authors:  F Boisgérault; J Mounier; V Tieng; M C Stolzenberg; I Khalil-Daher; M Schmid; P Sansonetti; D Charron; A Toubert
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.